Modulators of ATP-binding cassette transporters
AssigneeVertex Pharamaceuticals Incorporated
InventorsSara S Hadida Ruah, Mark T. Miller, Brian Bear, Jason McCartney, Peter D. J. Grootenhuis
Life of this patent
Estimating the term…
Abstract
Compounds of the present invention and pharmaceutically acceptable compositions thereof, are useful as modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator (“CFTR”). The present invention also relates to methods of treating ABC transporter mediated diseases using compounds of the present invention.
Claims10
A method of treating or lessening the severity of a disease in a patient, wherein said disease is pancreatic insufficiency or male infertility comprising the step of administering to said patient an effective amount of a compound of formula I:
- or a pharmaceutically acceptable salt thereof, wherein:
- Each R1 is independently an optionally substituted C1-6 aliphatic, an optionally substituted aryl, an optionally substituted C3-10 membered cycloaliphatic, carboxy, amido, amino, halo, or hydroxy, provided that at least one R1 is an optionally substituted aryl and said R1 is attached to the 3- or 4-position of the phenyl ring;
- R2 is hydrogen, an optionally substituted C1-6 aliphatic, an optionally substituted C3-6 cycloaliphatic, an optionally substituted phenyl, or an optionally substituted heteroaryl;
- Ring A is an optionally substituted cycloaliphatic;
- R4 is an optionally substituted benzo[d][1,3]dioxolyl ring;
- and
- n is 1, 2, 3, 4, or 5.
Dependencies are inferred from the claim text.